10 completed, 1 active not recruiting. 11 Phase 1, 1 Phase 2.
By phase and status
Follow mitapivat: new trials by email Literature Review of mitapivat trials Research Report on mitapivat
Trials (filtered) newest first · largest first
All 11 trials
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
Study of How Mitapivat Affects Midazolam Blood Levels in Healthy Participants Mitapivat, Midazolam - Healthy Participants | Phase 1 | Completed | 20 | 2024-10-17 | 2025-01-28 |
A Pharmacokinetic Study of Mitapivat in Participants With Moderate Hepatic Impairment Compared to Matched Healthy Control Participants With Normal Hepatic Function Mitapivat - Moderate Hepatic Impairment | Phase 1 | Completed | 20 | 2023-01-10 | 2023-09-21 |
A Study to Compare the Pharmacokinetics and Safety of Mitapivat 100 mg Tablet Formulation With Mitapivat 2 × 50 mg Tablet Formulation in Healthy Adult Participants Mitapivat tablet - Healthy Volunteers | Phase 1 | Completed | 26 | 2021-01-06 | 2021-04-13 |
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Long-term Mitapivat Dosing in Subjects With Stable Sickle Cell Disease: An Extension of a Phase I Pilot Study of Mitapivat Mitapivat - Sickle Cell Disease, Hemolytic Anemia | Phase 1 / Phase 2 | Active not recruiting | 15 | 2020-12-09 | 2026-11-17 |
A Study to Assess the Relative Bioavailability and Effect of Food on the Coated Granule Formulation of Mitapivat in Healthy Participants Mitapivat tablets, Mitapivat coated granules - Healthy Volunteers | Phase 1 | Completed | 32 | 2020-09-21 | 2020-12-10 |
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Mitapivat (AG-348) in Healthy Adult Participants Placebo for Treatment A, Mitapivat 100 mg, Placebo for Treatment B - Healthy Volunteers | Phase 1 | Completed | 32 | 2020-06-17 | 2021-02-18 |
Study to Evaluate the Effect of Multiple Doses of Itraconazole and Rifampin on the Single-Dose Pharmacokinetics of Mitapivat Sulfate (AG-348) in Healthy Adult Participants itraconazole, rifampin, mitapivat sulfate - Healthy Volunteers | Phase 1 | Completed | 28 | 2019-06-20 | 2019-10-23 |
A Study to Evaluate the Absorption, Distribution, Metabolism, Excretion and Absolute Bioavailability of AG-348 in Healthy Male Participants Following Administration of a Single Oral Dose of [14C]AG-348 and Concomitant Single Intravenous Microdose of [13C6]AG-348 AG-348, [13C6]AG-348 - Healthy Volunteers | Phase 1 | Completed | 8 | 2018-05-24 | 2018-10-12 |
Study to Evaluate the Pharmacokinetics, Safety, and QTc Effect of AG-348 in Healthy Subjects of Japanese Origin and Non-Asian Origin AG-348 - Healthy, Japanese | Phase 1 | Completed | 60 | 2017-08-09 | 2017-10-19 |
A Phase I Study of AG-348 in Healthy Volunteers AG-348, Placebo - Healthy Volunteer | Phase 1 | Completed | 48 | 2014-05-01 | 2014-11-10 |
A Phase I Study of AG-348 in Healthy Volunteers AG-348, Placebo - Healthy Volunteer | Phase 1 | Completed | 48 | 2014-03-01 | 2014-10-22 |
Conditions studied
Anemia, Hemolytic (1) · Anemia, Sickle Cell (1)
Sponsors
Agios Pharmaceuticals, Inc. (10) · National Heart, Lung, and Blood Institute (NHLBI) (1)
Countries
United States (11)
Top investigators
Samuel Agresta, MD, MPH & TM (2) · Swee Lay Thein, M.D. (1)
Results publications
PMID 30091852, PMID 38450513, PMID 41809202